TiLV Disease – Tilapia lake virus is a newly emerging virus that is associated with significant moralities in farmed Tilapia. With cases reported across Africa, Asia and South America, the virus represents a huge risk to the global Tilapia industry, whose 2015 production was valued at USD 9.8 billion.

We conducted field trails with the TV1 – The vaccine against Tilapia Lake Virus (TiLV)

TV1 Field test against TiLVTV1 Field test vaccine against TiLVTV1 Field test vaccine1 against TiLVTV1 Vaccinated fish against TiLVTVL Tilv field test - diagnosis in the field

Kovax developed a vaccine to this disease.

Safe and efficient vaccine – Fish vaccinated with TV1 Vaccine showed no sign of disease and were comparable in behavior to the unchallenged placebo group. Mortality level of 2.9% (a single fish) was observed throughout the observation period.

TV1 Safety and efficacy

Comments are closed.